Troy Edward Wilson net worth and biography

Troy Wilson Biography and Net Worth

President and Chief Executive Officer of Kura Oncology

Troy E. Wilson, Ph.D., J.D., is one of Kura’s co-founders and has served as President, CEO and Chairman of Kura’s Board of Directors since inception in August 2014. He also co-founded Avidity Biosciences (NASDAQ: RNA) and has served as Chairman of its Board of Directors since its inception in 2013. Previously, he co-founded and served as President and CEO of Araxes Pharma LLC and Wellspring Biosciences, Inc., where his team pioneered the discovery and development of small molecules inhibitors of the KRAS oncoprotein. Earlier in his career, Dr. Wilson co-founded and served as President and CEO of Intellikine, a private biopharmaceutical company, acquired by Takeda Pharmaceutical Company Limited in 2011, and he co-founded and served as Chief Business Officer of Ambrx (NASDAQ: AMAM), acquired by Johnson & Johnson Innovative Medicines in 2024. He serves as a director of Puma Biotechnology and Cartography Biosciences. Dr. Wilson holds a law degree from New York University and graduated with a Ph.D. in bioorganic chemistry and a B.A. in biophysics from the University of California, Berkeley.

What is Troy Edward Wilson's net worth?: The estimated net worth of Troy Edward Wilson is at least $2.96 million as of September 29th, 2025. Dr. Wilson owns 246,853 shares of Kura Oncology stock worth more than $2,957,299 as of December 4th. This net worth estimate does not reflect any other assets that Dr. Wilson may own. Additionally, Dr. Wilson receives a salary of $1,220,000.00 as President and Chief Executive Officer at Kura Oncology. Learn More about Troy Edward Wilson's net worth.
How old is Troy Edward Wilson?: Dr. Wilson is currently 55 years old. There are 5 older executives and no younger executives at Kura Oncology. Learn More on Troy Edward Wilson's age.
What is Troy Edward Wilson's salary?: As the President and Chief Executive Officer of Kura Oncology, Inc., Dr. Wilson earns $1,220,000.00 per year. Learn More on Troy Edward Wilson's salary.
How do I contact Troy Edward Wilson?: The corporate mailing address for Dr. Wilson and other Kura Oncology executives is 12730 HIGH BLUFF DRIVE SUITE 400, SAN DIEGO CA, 92130. Kura Oncology can also be reached via phone at (858) 500-8800 and via email at [email protected]. Learn More on Troy Edward Wilson's contact information.
Has Troy Edward Wilson been buying or selling shares of Kura Oncology?: Troy Edward Wilson has not been actively trading shares of Kura Oncology in the last ninety days. Most recently, Troy Edward Wilson sold 36,615 shares of the business's stock in a transaction on Monday, September 29th. The shares were sold at an average price of $8.94, for a transaction totalling $327,338.10. Following the completion of the sale, the chief executive officer now directly owns 246,853 shares of the company's stock, valued at $2,206,865.82. Learn More on Troy Edward Wilson's trading history.
Who are Kura Oncology's active insiders?: Kura Oncology's insider roster includes Teresa Bair (Chief Legal Officer), Thomas Doyle (SVP, Finance and Accounting), Kathleen Ford (Chief Operating Officer), Laura Johnson (Director), Mollie Leoni (Chief Medical Officer), Thomas Malley (Director), Anthony Praill (CFO), Troy Wilson (President and Chief Executive Officer), and Saiid Zarrabian (Insider). Learn More on Kura Oncology's active insiders.
Are insiders buying or selling shares of Kura Oncology?: In the last twelve months, Kura Oncology insiders bought shares 1 times. They purchased a total of 50,000 shares worth more than $410,000.00. In the last twelve months, insiders at the sold shares 16 times. They sold a total of 137,521 shares worth more than $1,308,039.69. The most recent insider tranaction occured on November, 14th when insider Teresa Brophy Bair sold 8,804 shares worth more than $98,428.72. Insiders at Kura Oncology own 6.4% of the company. Learn More about insider trades at Kura Oncology.
Information on this page was last updated on 11/14/2025.

Troy Edward Wilson Insider Trading History at Kura Oncology

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/29/2025	Sell	36,615	$8.94	$327,338.10	246,853
9/8/2025	Buy	50,000	$8.20	$410,000.00	100,968
1/24/2024	Sell	91,052	$20.23	$1,841,981.96	559
10/8/2020	Sell	261,692	$33.24	$8,698,642.08	32,682
10/6/2020	Sell	100	$32.00	$3,200.00	32,682
9/14/2020	Sell	98,490	$28.82	$2,838,481.80	46,022
9/10/2020	Sell	37,030	$28.00	$1,036,840.00	65,126
9/8/2020	Sell	50,000	$26.00	$1,300,000.00	65,126
8/25/2020	Sell	29,621	$22.30	$660,548.30	34,664
8/19/2020	Sell	75,335	$22.02	$1,658,876.70	28,096
8/17/2020	Sell	12,901	$22.00	$283,822.00	28,096

Troy Edward Wilson Buying and Selling Activity at Kura Oncology

Kura Oncology Company Overview

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, an orally bioavailable small molecule inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a farnesyl transferase inhibitor for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification. The company was founded in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $11.98

$11.90

$12.32

50 Day Range

MA: $10.37

$8.85

$12.09

2 Week Range

Now: $11.98

$5.41

$12.49

Volume

1,438,355 shs

Average Volume

1,795,837 shs

Market Capitalization

$1.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21

Troy Wilson Biography and Net Worth

What is Troy Edward Wilson's net worth?

How old is Troy Edward Wilson?

What is Troy Edward Wilson's salary?

How do I contact Troy Edward Wilson?

Has Troy Edward Wilson been buying or selling shares of Kura Oncology?

Who are Kura Oncology's active insiders?

Are insiders buying or selling shares of Kura Oncology?